Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
American Journal of Translational Research|June 10, 2011
The roles of EZH2 in cell lineage commitmentRuey-Hwang Chou, Yung-Luen Yu, Mien-Chie HungBiochemical and Biophysical Research Communications|September 22, 2020
Blocking the interface region amongst S100A6 and RAGE V domain via S100B proteinHsin-Yen Sung, Deepu Dowarha, Ruey-Hwang Chou, et al.Plos One|September 7, 2016
Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using TranilastJian Wei Chiou, Brian Fu, Ruey-Hwang Chou, et al.Biomolecules|April 30, 2021
S100P Interacts with p53 while Pentamidine Inhibits This InteractionRevansiddha H Katte, Deepu Dowarha, Ruey-Hwang Chou, et al.Plos One|February 20, 2019
S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domainMd Imran Khan, Tai Yuan, Ruey-Hwang Chou, et al.Cell Transplantation|February 4, 2015
The potential roles of EZH2 in regenerative medicineRuey-Hwang Chou, Lian Chiu, Yung-Luen Yu, et al.Frontiers in Chemistry|January 20, 2022
Synthesis of Novel Suramin Analogs With Anti-Proliferative Activity <i>via</i> FGF1 and FGFRD2 BlockadeNuzhat Parveen, Yan-Liang Lin, Ruey-Hwang Chou, et al.Biochimica Et Biophysica Acta|September 26, 2013
Structural insights into the interaction of human S100B and basic fibroblast growth factor (FGF2): Effects on FGFR1 receptor signalingArun A Gupta, Ruey-Hwang Chou, Hongchun Li, et al.Biochemical and Biophysical Research Communications|July 9, 2016
Suramin blocks interaction between human FGF1 and FGFR2 D2 domain and reduces downstream signaling activityZong-Sian Wu, Che Fu Liu, Brian Fu, et al.Plos One|May 10, 2019
Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domainMd Imran Khan, Deepu Dowarha, Revansiddha Katte, et al.Pageof 8